SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Krishan A. Rapid flow-cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 1975; 66: 763.
  • 2
    Crissman HA, Steinkamp JA. Rapid, simultaneous measurement of DNA, protein, and cell volume in single cells from large mammalian cell populations. J Cell Biol 1973; 59: 766.
  • 3
    Dean PN, Jett JH: Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 1974;60:523.
  • 4
    Bagwell CB. Theory and application of DNA histogram analysis [Dissertation]. University of Miami, ERIC/EDRS ED 299 130, 1979.
  • 5
    Bagwell CB. Theoretical aspects of flow cytometry data analysis. In: BauerKD, DuqueRE, ShankeyTV, editors. Clinical flow cytometry, 1st edition. Baltimore: Williams & Wilkins; 1993. p 4161.
  • 6
    Rabinovitch PS. Practical considerations for DNA content and cell cycle analysis. In: BauerKD, DuqueRE, ShankeyTV, editors. Clinical flow cytometry, 1st edition. Baltimore: Williams & Wilkins; 1993. p 117142.
  • 7
    McDivitt RW, Stone KR, Meyer JS. A method for dissociation of viable human breast cancer cells that produces flow cytometric kinetic information similar to that obtained by thymidine labeling. Cancer Res 1984; 44: 26282633.
  • 8
    McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC. A proposed classification of breast cancer based on kinetic information. Derived from comparison of risk factors in 168 primary operable breast cancers. Cancer 1986; 57: 269276.
  • 9
    Meyer JS, Coplin MD. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations. Am J Clin Pathol 1988; 89: 586595.
  • 10
    Scheck LE, Muirhead KA, Horan PK. Evaluation of S phase distribution of flow cytometric DNA histograms by autoradiography and computer algorithms. Cytometry 1980; 1: 109117.
  • 11
    Barlogie B, Göhde W, Johnston DA, Smallwood L, Schumann J, Drewinko B, Freireich EJ. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res 1978; 38: 33333339.
  • 12
    Barlogie B, Drewinko B, Schumann J, Göhde W, Dosik G, Latreille J, Johnston DA, Freireich EJ. Cellular DNA content as a marker of neoplasia in man. Am J Med 1980; 69: 195203.
  • 13
    Böhm N, Sandritter W. DNA in human tumors: a cytophotometric study. Curr Top Pathol 1975; 60: 151219.
  • 14
    Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Göhde W, Andreeff M, Freireich EJ. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 39823997.
  • 15
    Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 1984; 37: 961974.
  • 16
    Merkel DE, McGuire WL. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer 1990; 65: 11941205.
  • 17
    Silvestrini R. Relevance of DNA-ploidy as a prognostic instrument for solid tumors. Ann Oncol 2000; 11: 259261.
  • 18
    Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 1989; 15: 118.
  • 19
    Seckinger D, Sugarbaker E, Frankfurt O. DNA content in human cancer. Application in pathology and clinical medicine. Arch Pathol Lab Med 1989; 113: 619626.
  • 20
    Koss LG, Czerniak B, Herz F, Wersto RP. Flow cytometric measurements of DNA and other components in human tumors: a critical appraisal. Hum Pathol 1989; 20: 528648.
  • 21
    Ellis CN, Burnette JJ, Sedlak R, Dyas C, Blakemore WS. Prognostic applications of DNA analysis in solid malignant lesions in humans. Surg Gynecol Obstet 1991; 173: 329342.
  • 22
    Hedley DW, Shankey TV, Wheeless LL. DNA cytometry consensus conference. Cytometry 1993; 14: 471471.
  • 23
    Hedley DW. Breast cancer. In: BauerKD, DuqueRE, ShankeyTV, editors. Clinical flow cytometry principles and application, 1st edition. Baltimore: Williams & Wilkins; 1993. p 247261.
  • 24
    Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989; 320: 627633.
  • 25
    Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer: a study with long-term follow-up. Br J Cancer 1989; 60: 693700.
  • 26
    Sigurdsson H, Baldetorp B, Borg Å, Dalberg M, Fernö M, Killander D, Olsson H. Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990; 322: 10451053.
  • 27
    Stål O, Dufmats M, Hatschek T, Carstensen J, Klintenberg C, Rutqvist L-E, Skoog L, Sullivan S, Wingren S, Nordenskjöld B. S-phase fraction is a prognostic factor in stage I breast carcinoma. J Clin Oncol 1993; 11: 17171722.
  • 28
    Muss HB, Kute TE, Case LD, Smith LR, Booher C, Long R, Kammire L, Gregory B, Brockschmidt JK. The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer 1989; 64: 18941900.
  • 29
    Silvestrini R, Daidone MG, Del Bino G, Mastore M, Luisi A, Di Fronzo G, Boracchi P. Prognostic significance of proliferative activity in node-negative breast cancer. Ann Oncol 1993; 4: 213219.
  • 30
    Merkel DE, Winchester DJ, Goldschmitt RA, August CZ, Wruck DM, Rademaker AW. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Cancer 1993; 72: 19261932.
  • 31
    Witzig TE, Ingle JN, Cha SS, Schaid DJ, Tabery RL, Wold LE, Grant C, Gonchoroff NJ, Katzmann JA. DNA ploidy and percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer 1994; 74: 17521761.
  • 32
    Robert NJ. Biologic indicators of prognosis in breast cancer. Hosp Pract Off Ed 1990; 25: 9398, 101–102.
  • 33
    O'Reilly SM, Richards MA. Is DNA flow cytometry a useful investigation in breast cancer? Eur J Cancer 1992; 28: 504507.
  • 34
    Norman A, McBride W. Prognostic indicators in node-negative breast cancer. Am J Clin Oncol (CCT) 190;13: 269270.
  • 35
    Wenger CR, Clark GM. S-phase fraction and breast cancer: a decade of experience. Breast Cancer Res Treat 1998; 51: 255265.
  • 36
    Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley S, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 966978.
  • 37
    American Society of Clinical Oncology. Clinical guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1996; 14: 28432877.
  • 38
    Shankey TV, Rabinovitch P, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14: 472477.
  • 39
    Dressler LG, Seamer LC, Owens M, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61: 420427.
  • 40
    Baldetorp B, Stål O, Ahrens O, Cornelisse C, Corver W, Falkmer U, Fernö M on behalf of the Swedish Society of Cancer Study Group. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? Cytometry 1998; 33: 385393.
  • 41
    Lee GM, Thornthwaite JT, Rasch EM. Picogram per cell determination of DNA by flow cytofluorometry. Anal Biochem 1984; 137: 221226.
  • 42
    Vindeløv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flowcytometric DNA analysis. Cytometry 1983; 3: 323327.
  • 43
    Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA. Convention on nomenclature for DNA cytometry. Cytometry 1984; 5: 445446.
  • 44
    Statistica, Statistics II, 2nd edition, Volume IIII, SUR-3488-3490.
  • 45
    Cox DR. Regression models and life-tables. J R Stat Soft (B) 1972; 34: 187220.
  • 46
    Cusick EL, Milton JI, Ewen SWB. The resolution of aneuploid DNA stem lines by flow cytometry: limitations imposed by the coefficient of variation and the percentage of aneuploid nuclei. Anal Cell Pathol 1990; 2: 139148.
  • 47
    Gnant MFX, Blijham GH, Reiner A, Schemper M, Reynders M, Schutte B, van Asche C, Steger G, Jakesz R. Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer: 10-year results. Ann Oncol 1993; 4: 643650.
  • 48
    Fernö M, Baldetorp B, Borg Å, Olsson H, Sigurdsson H, Killander D. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol 1992; 31: 157165.
  • 49
    Auer GU, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Anal Quant Cytol 1980; 2: 161165.
  • 50
    Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Åkerman M, Killander D. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 1992; 13: 577585.
  • 51
    Kubbies M. Flow cytometric DNA-histogram analysis: non-stoichiometric fluorochrome binding and pseudoaneuploidy. J Pathol 1992; 167: 413419.
  • 52
    Alanen KA, Joensuu H, Klemi PJ. Autolysis is a potential of false aneuploid peaks in flow cytometric DNA histograms. Cytometry 1989; 10: 417425.
  • 53
    Joensuu H, Alanen KA, Klemi PJ, Aine R. Evidence for false aneuploid peaks of paraffin-embedded tissue. Cytometry 1990; 11: 431437.
  • 54
    Pollack A, Ciancio G, Terry NHA, Block NL. Recognition and reduction of artifacts from autolysis in paraffin-embedded tissue using DNA/nuclear protein flow cytometry. Cytometry 1993; 14: 565568.
  • 55
    Balslev I, Christensen IJ, Brunn Rasmussen B, Larsen JK, Lykkesfeldt AE, Thorpe SM, Rose C, Briand P, Mouridsen HT. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer. Int J Cancer 1994; 56: 1625.
  • 56
    Stål O, Wingren S, Carstensen J, Rutqvist LE, Skoog L, Klintenberg C, Nordenskjöld B. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. Eur J Cancer Clin Oncol 1989; 25: 301309.
  • 57
    Uyterlinde AM, Baak JPA, Schipper NW, Peterse H, Matze E, Meijer CJL. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast cancer patients with long follow-up. Int J Cancer 1990; 45: 17.
  • 58
    Joensuu H, Toikkanen S, Klemi PJ. DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Cancer 1990; 66: 331340.
  • 59
    Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194(4260): 2328.
  • 60
    Hedley DW, Rugg CA, Gelber RD. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 1987; 47: 47294735.
  • 61
    Haag D, Feichter G, Goerttler K, Kaufmann M. Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas. Cytometry 1987; 8: 377385.
  • 62
    Baldetorp B, Fernö M, Bendahl P-O, Fallenius G, Idvall I, Åkerman M, Killander D. Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer? Anal Quant Cytol Histol 1998; 20(2).
  • 63
    Sigurdsson H, Baldetorp B, Borg Å, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Flow cytometry in primary breast cancer: improving the prognostic value of fraction of cells in the S-phase by optimal cathegorisation of cut-off levels. Br J Cancer 1990; 62: 786790.
  • 64
    Dettmar P, Harbeck N, Thomssen C, Pache L, Ziffer P, Fizi K, Jänicke F, Nathrath W, Schmitt M. Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer. Br J Cancer 1997; 75: 15251533.
  • 65
    Kallioniemi O-P, Visakorpi T, Holli K, Isola JJ, Rabinovitch P. Automated peak detection and cell cycle analysis of flow cytometric DNA histograms. Cytometry 1994; 16: 250255.
  • 66
    Glogovac JK, Malone KE, Heagerty PJ, Doody D, Lin MG, Uiprasertkul M, Daling JR, Rabinovitch PS, Porter PL. Improved prognostic significance of S-phase and identification of aneuploid sub-groups using bivariate DNA content and cytokeratin label flow cytometry: analysis of 665 young women with breast cancer. San Antonio presentation 1999 (manuscript submitted).
  • 67
    Wingren S, Stål O, Sullivan S, Brisfors A, Nordenskjöld B. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer. Int J Cancer 1994; 59: 710.
  • 68
    Visscher DW, Zarbo RJ, Jacobsen G, Kambouris A, Talpos G, Sakr W, Crissman JD. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinoma by flow cytometry. Lab Invest 1990; 62: 370378.
  • 69
    Baldetorp B, Bendahl P-O, Fernö M, Alanen K, Delle U, Falkmer U, Hansson-Aggesjö B, Höckenström T, Lindgren A, Mossberg L, Nordling S, Sigurdsson H, Stål O, Visakorpi T. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Cytometry 1995; 22: 115127.
  • 70
    Alvegård TA, Berg NO, Baldetorp B, Fernö M, Killander D, Ranstam J, Rydholm A, Åkerman M. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: The Scandinavian Sarcoma Group Experience. J Clin Oncol 1990; 8: 538547.